Gynecologic Cancer
From the Journals
Gaps in patient-provider survivorship communication persist
Over a recent 5-year period, there was little change in the percentages of patients who reported not having any detailed discussion with providers...
News
FDA approves bevacizumab-bvzr for several cancers
The bevacizumab biosimilar is now approved for metastatic colorectal cancer, advanced non-squamous non–small cell lung cancer, recurrent...
From the Journals
Chemoradiotherapy no better than chemo alone in endometrial carcinoma
In a phase 3 trial of patients with stage III or IVA endometrial cancer, the proportion of patients alive and relapse free at 60 months was 59%...
From the Journals
Niraparib-pembrolizumab combo finds niche in breast, ovarian cancers
The combination had good antitumor activity, as well as good safety and tolerability, in patients with advanced TNBC or ovarian carcinoma who were...
Conference Coverage
Nearly two-thirds of gynecologic oncology respondents experienced sexual harassment
CHICAGO – A survey suggests sexual harassment remains rampant in the gynecologic oncology field, with both women and...
From the Journals
Cediranib may alter DNA repair capacity
The preclinical finding may have implications for the development of combination treatment with olaparib for cancer patients.
Conference Coverage
Targeted sequencing panel IDs Lynch syndrome in women with/at risk for endometrial cancer
NASHVILLE, TENN. – A targeted next-generation sequencing panel rapidly IDs Lynch syndrome pathogenic mutations in...
From the Journals
Anomalous RT dose linked to lower survival in uterine cancer
Women with uterine cancer whose radiation therapy records show anomalies in treatment have lower 5-year overall survival.
From the Journals
Thrice yearly cytologic testing may best annual cervical screenings
Or a dual stain cytologic procedure may replace them.
From the Journals
Vaginal brachytherapy more toxic than pelvic RT in endometrial carcinoma
Vaginal brachytherapy plus chemotherapy did not show superiority over pelvic RT in terms of recurrence free or overall survival, and showed higher...
Opinion
Lessons from KEYNOTE-158 and the role of R-CHOP
Dr. Alan P. Lyss breaks down the clinical relevance of two recent studies in advanced cervical cancer and diffuse large B-cell lymphoma.